GSK plc (GSK)

GSK Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	12,578	5,902	10,616	4,921	3,516
Depreciation & Amortization	2,314	2,551	2,294	-	-
Stock-Based Compensation	374	344	307	-	-
Other Adjustments	5,837	7,907	4,977	3,023	3,733
Change in Receivables	-613	298	-794	-	-
Changes in Inventories	-140	-294	-424	-	-
Changes in Accounts Payable	131	-179	-15	-	-
Changes in Income Taxes Payable	-1,202	-1,307	-1,328	-1,473	-1,291
Changes in Other Operating Activities	-1,280	431	377	-	-
Operating Cash Flow	16,684	14,415	14,864	769	1,675
Operating Cash Flow Growth	15.74%	-3.02%	1832.90%	-54.09%	-9.61%
Capital Expenditures	-1,348	-1,399	-1,314	-1,143	-950
Sale of Property, Plant & Equipment	24	65	28	146	132
Purchases of Intangible Assets	-1,637	-1,583	-1,030	-1,115	-1,704
Proceeds from Sale of Intangible Assets	115	131	12	196	641
Purchases of Investments	-135	-103	-124	-144	-163
Proceeds from Sale of Investments	189	2,357	1,832	238	479
Payments for Business Acquisitions	-1,692	-805	-1,457	-3,108	-
Proceeds from Business Divestments	40	-	-	-43	-17
Other Investing Activities	-1,096	-977	-1,121	-3,799	-195
Investing Cash Flow	-4,233	-1,229	-1,595	-8,772	-1,777
Short-Term Debt Issued	1,215	-545	-333	1,021	301
Short-Term Debt Repaid	-288	-81	-	-	-2,304
Net Short-Term Debt Issued (Repaid)	927	-626	-333	1,021	-2,003
Long-Term Debt Issued	1,979	1,075	223	1,025	-
Long-Term Debt Repaid	-1,641	-1,841	-2,457	-6,870	-181
Net Long-Term Debt Issued (Repaid)	338	-766	-2,234	-5,845	-181
Issuance of Common Stock	15	20	10	25	21
Repurchase of Common Stock	-1,377	-	-	-	-
Net Common Stock Issued (Repurchased)	-1,362	20	10	25	21
Common Dividends Paid	-2,564	-2,444	-2,247	-3,467	-3,999
Other Financing Activities	-1,024	-910	-837	9,089	-1,427
Financing Cash Flow	-3,685	-4,726	-5,641	823	-7,589
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-19	-54	-99	152	-29
Net Cash Flow	8,747	8,406	7,529	-7,028	-7,720
Free Cash Flow	15,336	13,016	13,550	-374	725
Free Cash Flow Growth	17.82%	-3.94%	-	-	-16.09%
FCF Margin	-	-	-	-1.28%	2.94%
Free Cash Flow Per Share	7.45	6.28	6.59	-0.18	0.36
Levered Free Cash Flow	5,456	986	1,951	7,516	-40
Unlevered Free Cash Flow	5,215	3,216	5,494	3,009	2,016

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q